HEALTH Erasca Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate ERAS-0015 in Combination with KEYTRUDA® (Pembrolizumab) Monday, May 11, 2026 · inc., erasca Advertisement Read Original Article → Related Dispatches [US] · Jun 28 How people can use Narcan to save a life [US] · Jun 28 UK's Likely Next Leader Burnham to Unveil Plan to Shift Power From London [CA] · Jun 28 Researchers discover a cause of neuron excitability in ALS, suggesting a new potential treatment - Medical Xpress